Abstract
Cancer patients and survivors frequently experience cognitive deficits, including problems with attention and memory. These symptoms, referred to as cancer-related cognitive dysfunction (CRCD), are associated with distress. Learning about CRCD and self-management strategies may improve functioning and quality of life in cancer survivors. This study describes the development and evaluation of a CRCD resource for cancer patients. An educational booklet was developed in accordance with multiple evidence-based guidelines for cancer patient education. Cancer patients on chemotherapy (N = 113; 34% men; median age 55, range 19–85) reviewed the booklet and self-reported CRCD knowledge before and after reading the booklet. They also gave ratings on general impressions of the booklet. Seventy-five percent of participants reported that the resource increased their self-reported CRCD knowledge. A Wilcoxon signed-rank test demonstrated that exposure to the booklet elicited a statistically significant change in self-reported knowledge (Z = − 7.13, p < 0.001). A repeated-measures ANCOVA determined that the means of self-reported CRCD knowledge were significantly different between pre- and post-exposure (F(1, 92) = 7.96, p = 0.006, η2 = 0.08). Exploratory analyses revealed that self-reported CRCD knowledge increased across all educational attainment levels from pre- to post-exposure. Ninety-one percent of participants reported that all patients undergoing cancer treatment would find this booklet helpful. Cancer patients at risk for cognitive challenges gained self-reported CRCD knowledge from the booklet, and they think this knowledge would be helpful to others. A resource that makes CRCD understandable and manageable can bridge the gap in self-rated knowledge across education levels.
Similar content being viewed by others
References
World Health Organization. Cancer burden rise to 18.1 million new cases and 9.6 million cancer deaths in 2018, Last updated 2018 09 12
Side effects of chemotherapy. Canadian Cancer Society. https://www.cancer.ca/en/cancer-information/diagnosis-and-treatment/chemotherapy-and-other-drug-therapies/chemotherapy/side-effects-of-chemotherapy/?region=on. Accessed 25 May 2020
Schmidt JE, Beckjord E, Bovbjerg DH, Low CA, Posluszny DM, Lowery AE, Dew MA, Nutt S, Arvey SR, Rechis R (2016) Prevalence of perceived cognitive dysfunction in survivors of a wide range of cancers: results from the 2010 LIVESTRONG survey. J Cancer Surviv 10(2):302–311. https://doi.org/10.1007/s11764-015-0476-5
Edelstein K, Bernstein LJ (2014) Cognitive dysfunction after chemotherapy for breast cancer. J Int Neuropsychol Soc 20(4):351–356. https://doi.org/10.1017/S1355617714000149
Tannock IF, Ahles TA, Ganz PA, van Dam FS (2004) Cognitive impairment associated with chemotherapy for cancer: report of a workshop. J Clin Oncol 22(11):2233–2239. https://doi.org/10.1200/JCO.2004.08.094
Collins B, MacKenzie J, Tasca GA, Scherling CS, Smith A (2013) Cognitive effects of chemotherapy in breast cancer patients: a dose-response study. Psycho-Oncology 22(7):1517–1527. https://doi.org/10.1002/pon.3163
Ahles TA, Root JC, Ryan EL (2012) Cancer- and cancer treatment-associated cognitive change: an update on the state of the science. J Clin Oncol 30(30):3675–3686. https://doi.org/10.1200/JCO.2012.43.0116
Bernstein LJ, McCreath GA, Komeylian Z, Rich JB (2017) Cognitive impairment in breast cancer survivors treated with chemotherapy depends on control group type and cognitive domains assessed: a multilevel meta-analysis. Neurosci Biobehav Rev 83:417–428. https://doi.org/10.1016/j.neubiorev.2017.10.028
Vardy JL, Dhillon HM, Pond GR, Rourke SB, Bekele T, Renton C, Dodd A, Zhang H, Beale P, Clarke S, Tannock IF (2015) Cognitive function in patients with colorectal cancer who do and do not receive chemotherapy: a prospective, longitudinal, controlled study. J Clin Oncol 33(34):4085–4092. https://doi.org/10.1200/JCO.2015.63.0905
Gan HK, Bernstein LJ, Brown J, Ringash J, Vakilha M, Wang L, Goldstein D, Kim J, Hope AJ, O’Sullivan B, Waldron J, Abdul AR, Razak EX, Chen EX, Siu LL (2011) Cognitive functioning after radiotherapy or chemoradiotherapy for head-and-neck cancer. Int J Radiat Oncol Biol Phys 81(1):126–134. https://doi.org/10.1016/j.ijrobp.2010.05.004
Zer A, Pond GR, Razak AR, Tirona K, Gan HK, Chen EX, O’Sullivan B, Waldron J, Goldstein DP, Weinreb I, Hope AJ, Kim JJ, Chan KKW, Chan AK, Siu LL, Bernstein LJ (2018) Association of neurocognitive deficits with radiotherapy or chemoradiotherapy for patients with head and neck cancer. JAMA Otolaryngology- Head & Neck Surgery 144(1):71–79. https://doi.org/10.1001/jamaoto.2017.2235
Bernstein LJ, Pond GR, Gan HK, Tirona K, Chan KK, Hope AJ, Kim JJ, Chen EX, Siu LL, Abdul AR, Razak (2018) Pretreatment neurocognitive function and self-reported symptoms in patients with newly diagnosed head and neck cancer compared with noncancer cohort. Head Neck 40(9):2029–2042. https://doi.org/10.1002/hed.25198
McDonnell LJ, Ringash J, Xu W, Chan B, Lu L, Waldron J, Rock K, So N, Huang SH, Giuliani M, Hope AJ, O’Sullivan B, Bratman SV, Cho J, Kim J, Jang R, Bayley A, Lori J. Bernstein. (2019) Cross sectional study in cognitive and neurobehavioral impairment in long-term nasopharyngeal cancer survivors treated with intensity-modulated radiotherapy. Radiol Oncol 131:179–185. https://doi.org/10.1016/j.radonc.2018.09.012
Simo M, Gurtubay-Antolin A, Vaquero L, Bruna J, Rodriguez-Fornells A (2018) Performance monitoring in lung cancer patients pre- and post-chemotherapy using fine-grained electrophysiological measures. Neuroimage: Clinical 18:86–96. https://doi.org/10.1016/j.nicl.2017.12.032
Pearre DC, Bota DA (2018) Chemotherapy-related cognitive dysfunction and effects on quality of life in gynecologic cancer patients. Expert Review of Quality of Life in Cancer Care 3(1):19–26. https://doi.org/10.1080/23809000.2018.1443811
Wu LM, Tanenbaum ML, Dijkers MP, Amidi A, Hall SJ, Penedo FJ, Diefenbach MA (2016) Cognitive and neurobehavioral symptoms in patients with non-metastatic prostate cancer treated with androgen deprivation therapy or observation: a mixed methods study. Soc Sci Med 156:80–89. https://doi.org/10.1016/j.socscimed.2016.03.016
Saeed O, Bernstein LJ, Fazelzad R, Samuel M, Burmeister LA, Thabane L, Ezzat S, Goldstein DP, Jones J, Sawka AM (2019) Cognitive functioning in thyroid cancer survivors: a systematic review and meta-analysis. J Cancer Surviv 13(2):231–243. https://doi.org/10.1007/s11764-019-00745-1
Munir F, Burrows J, Yarker J, Kalawsky K, Bains M (2010) Women’s perceptions of chemotherapy-induced cognitive side effects on work ability: a focus group study. J Clin Nurs 19(9–10):1362–1370. https://doi.org/10.1111/j.1365-2702.2009.03006.x
Boykoff N, Moieni M, Subramanian SK (2009) Confronting chemobrain: an in-depth look at survivors’ reports of impact on work, social networks, and health care response. J Cancer Surviv 3(4):223–232. https://doi.org/10.1007/s11764-009-0098-x
Cappiello M, Cunningham RS, Tish Knobf MT, Erdos D (2007) Breast cancer survivors: information and support after treatment. Clin Nurs Res 16(4):278–301. https://doi.org/10.1177/1054773807306553
Longtin Y, Sax H, Leape LL, Sheridan SE, Donaldson L, Pittet D (2010) Patient participation: current knowledge and applicability to patient safety. Mayo Clin Proc 85(1):53–62. https://doi.org/10.4065/mcp.2009.0248
Keating NL, Landrum MB, Arora NK, Malin JL, Ganz PA, Van Ryn M, Week JC (2010) Cancer patients’ roles in treatment decisions: do characteristics of the decision influence roles? J Clin Oncol Off J Am Soc Clin Oncol 28(28):4364–4370. https://doi.org/10.1200/JCO.2009.26.8870
Street RL, Voigt B (1997) Patient participation in deciding breast cancer treatment and subsequent quality of life. Med Decis Mak 17(3):298–306. https://doi.org/10.1177/0272989X9701700306
Guadagnoli E, Ward P (1998) Patient participation in decision-making. Soc Sci Med 47(3):329–339. https://doi.org/10.1016/S0277-9536(98)00059-8
Bernstein LJ, McCreath GA, Nyhof-Young J, Dissanayake D, Rich JB (2018) A brief psychoeducational intervention improves memory contentment in breast cancer survivors with cognitive concerns: results of a single-arm prospective study. Support Care Cancer: The Official Journal of the Multinational Association of Supportive Care in Cancer 26(8):2851–2859. https://doi.org/10.1007/s00520-018-4135-z
Sani AM, Naab F, Aziato L (2016) Influence of educational level on knowledge and practice of breast self-examination among women in Sokoto, Nigeria. Journal of Basic and Clinical Reproductive Sciences 5(2):100–106. https://doi.org/10.4103/2278-960X.194482
Street RL, Voigt B, Geyer CJ, Manning T, Swanson GP (1995) Increasing patient involvement in choosing treatment for early breast cancer. Cancer 76(11):2275–2285. https://doi.org/10.1002/1097-0142(19951201)76:11<2275::aid-cncr2820761115>3.0.co;2-s
Veloso AG, Sperling C, Holm LV, Nicolaisen A, Rottmann N, Thayssen S, Christensen RD, Knudsen JL, Hansen DG (2013) Unmet needs in cancer rehabilitation during the early cancer trajectory- a nationwide patient survey. Acta Oncol 52(2):372–381. https://doi.org/10.3109/0284186X.2012.745648
Rawl SM, Dickinson S, Lee JL, Roberts JL, Teal E, Baker LB, Kianersi S, Haggstrom DA (2019) Racial and socioeconomic disparities in cancer-related knowledge, beliefs, and behaviors in Indiana. Cancer Epidemiol Biomark Prev 28(3):462–470. https://doi.org/10.1158/1055-9965.EPI-18-0795
Gilligan T, Coyle N, Frankel RM, Berry DL, Bohlke K, Epstein RM, Finlay E, Jackson VA, Lathan CS, Loprinzi CL, Nguyen LH, Seigel C, Baile WF (2017) Patient-clinician communication: American Society of Clinical Oncology Consensus Guideline. Obstet Gynecol Surv 73(2):96–97. https://doi.org/10.1200/JCO.2017.75.2311
der Heide Iris V, Wang J, Droomers M, Spreeuwenberg P, Rademakers J, Uiters E (2013) The relationship between health, education, and health literacy: results from the Dutch Adult Literacy and Life Skills Survey. J Health Commun 18(1):172–184. https://doi.org/10.1080/10810730.2013.825668
Tara A, Chafranskaia A, Nyhof-Young J (2012) Investigating the impact of socioeconomic status on the effectiveness of a pamphlet on achieving and maintaining bone health in breast cancer survivors: a patient education resource development primer. J Cancer Educ 27(1):54–58. https://doi.org/10.1007/s13187-011-0255-6
Papadakos Christine (Tina), Janet Papadakos, Pamela Catton, Patricia Houston, Patricia McKernan, and Audrey J. Friedman A. (2014) From theory to pamphlet: the 3Ws and an H process for the development of meaningful patient education resources. J Cancer Educ 29(2):304–310. https://doi.org/10.1007/s13187-013-0600-z
Patient & family education material guidelines. Revised March 2015: Nova Scotia Health Authority (Central Zone)
Writing health information for patients and families. 2014; 4th Edition: Available from: https://muhcpatienteducation.mcgill.ca/Writing_HI_Edition4.pdf. Accessed 20 Sept 2019
Aman S, Giuliani M, Papadakos J (2017) The persistence of the pamphlet: on the continued relevance of the health information pamphlet in the digital age. J Cancer Educ 32(3):483–486. https://doi.org/10.1007/s13187-015-0948-3
Raeke M. Cancer treatment side effect: Chemobrain. The University of Texas MD Anderson Cancer Centerhttps://www.mdanderson.org/publications/cancerwise/cancer-treatment-side-effect-chemobrain.h00-159143667.html. Accessed 20 September 2019
Memory, thinking & attention. Revised Feb 2014. BC Cancer. http://www.bccancer.bc.ca/health-info/coping-with-cancer/managing-symptoms-side-effects/memory-thinking-attention-problems.
Chemo brain. Revised Mar 2019. Mayo Clinic Cancer Center. https://www.mayoclinic.org/diseases-conditions/chemo-brain/symptoms-causes/syc-20351060. Accessed 20 September 2019
Cognitive changes after cancer treatment. LIVESTRONG. https://www.livestrong.org/we-can-help/finishing-treatment/cognitive-changes-after-cancer-treatment. Accessed 20 September 2019
Blanca MJ, Alarcon R, Arnau J, Bono R, Bendayan R (2017) Non-normal data: is ANOVA still a valid option? Psicothema 29(4):552–557. https://doi.org/10.7334/psicothema2016.383
James N, Daniels H, Rahman R, McConkey C, Derry J, Young A (2007) A study of information seeking by cancer patients and their carers. Curr Oncol 19(5):356–362. https://doi.org/10.1016/j.clon.2007.02.005
Hyde JS, Linn MC (1988) Gender differences in verbal ability: a meta-analysis. Psychol Bull 104(1):53–69. https://doi.org/10.1037/0033-2909.104.1.53
Weiss B (2008) Chemobrain: a translational challenge for neurotoxicology. Neurotoxicology 29(5):891–898. https://doi.org/10.1016/j.neuro.2008.03.009
Ringash J, Bernstein LJ, Devins G, Dunphy C, Giuliani M, Martino R, McEwen S (2018) Head and neck cancer survivorship: learning the needs, meeting the needs. Semin Radiat Oncol 28(1):64–74. https://doi.org/10.1016/j.semradonc.2017.08.008
Schmidt H (2018) The single-item questionnaire. Professions Educ 1–2 4(1):1–2. https://doi.org/10.1016/j.hpe.2018.02.001
Yao C, Rich JB, Tannock IF, Seruga B, Tirona K, Bernstein LJ, LJ. (2016) Pretreatment differences in intraindividual variability in reaction time between women diagnosed with breast cancer and healthy controls. J Int Neuropsychol Soc 22(5):530–539. https://doi.org/10.1017/S1355617716000126
Sinha P, Wong AWK, Kallogjeri D, Piccirillo JF (2018) Baseline cognition assessment among patients with oropharyngeal cancer using PROMIS and NIH toolbox. JAMA Otolaryngology Head & Neck Surgery 144(11):978–987. https://doi.org/10.1001/jamaoto.2018.0283
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
This study was approved by the University Health Network Research Ethics Board. All participants provided informed consent.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Abraham, E.H., Khan, B., Ling, E. et al. The Development and Evaluation of a Patient Educational Resource for Cancer-Related Cognitive Dysfunction. J Canc Educ 37, 111–119 (2022). https://doi.org/10.1007/s13187-020-01793-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13187-020-01793-3